Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses (Q33592768)

28 July 2017

title

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses (English)

1 reference

peripheral T-cell lymphoma

28 July 2017

main subject

1 reference

Barbara Pro

0 references

Swaminathan Padmanabhan

object named as

Swaminathan Padmanabhan Iyer

0 references

Steven Horwitz

1 reference

28 July 2017

Bertrand Coiffier

1 reference

28 July 2017

Barbara Pro

1 reference

28 July 2017

H Miles Prince

1 reference

28 July 2017

Francine Foss

1 reference

28 July 2017

Lubomir Sokol

1 reference

28 July 2017

Matthew Greenwood

1 reference

28 July 2017

Dolores Caballero

1 reference

28 July 2017

Franck Morschhauser

1 reference

28 July 2017

Martin Wilhelm

1 reference

28 July 2017

Lauren Pinter-Brown

1 reference

28 July 2017

Andrei Shustov

1 reference

28 July 2017

Tina Nielsen

1 reference

28 July 2017

Jean Nichols

1 reference

28 July 2017

Julie Wolfson

1 reference

28 July 2017

Barbara Balser

1 reference

28 July 2017

language of work or name

1 reference

23 January 2014

1 reference

Journal of Hematology & Oncology

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

start time

23 January 2014

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Chemical phylogenetics of histone deacetylases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Hematopoietic SCT for peripheral T-cell lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Management of peripheral T-cell non-Hodgkin's lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Anticancer activities of histone deacetylase inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Phenotypic analysis of peripheral T cell lymphoma among the Japanese

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016573

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-8722-7-11

Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification

21 January 2018

1 reference

12 December 2020

Peripheral T-cell lymphoma

1 reference

12 December 2020

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-8722-7-11

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference